Topics
Glioblastoma | Treatment | Clinical trials | Dabrafenib
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Dabrafenib
Salama
AKS, Wang V, Macrae ER, Park JI, Chen HX, Gray RJ, McShane LM,
Rubinstein LV, Patton D, Williams PM, Hamilton SR, Armstrong DK,
Tricoli JV, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP,
Flaherty KT.
Phase
II Study of Dabrafenib and Trametinib in Patients With Tumors With
BRAFV600E
Mutations:
Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131)
Subprotocol H.
JCO
Precis Oncol.
2026 Jan 14;10:e2500338.
doi:
10.1200/PO-25-00338. PMID:
41533998. Trial
registration ID:
NCT04439292.
ˍ